Thesis (M.Sc.) - Cairo University - Faculty of Physical Therapy - Department of Physical Therapy for Gynecology and Obstetrics

Background: De Quervain's Tenosynovitis ispainful stenosing tenosynovitis of the first dorsal compartment of the wrist that affecting physical function. So, it is necessary to decrease pain in De Quervain's tenosynovitis. Purpose: The purpose of this studywas to investigate the effect of the myofascial release on De Quervain's tenosynovitis in pregnant women. Subjects and methods:Thirty pregnant women diagnosed with De Quervain{u2019}s tenosynovitis, their age ranged from 20-35 years, their body mass index would be less than 30 kg/m2, their gestational age ranged from 20th to 28th weeks and the number of parity ranged (1-3) times. Women divided randomly into two equal groups in number, Group A (Control group): 15 patients, They treated by therapeutic ultrasound only for 6 weeks, 10 mins/session, 3 sessions/week. Group B (Study group): 15 patients, They treated by myofascial release for 6 weeks, 10 mins/session, 3 sessions/week plus therapeutic ultrasound. All participants were evaluated by visual analogue scale, patient rated wrist evaluation questionnaire, serum cortisol levels before and after treatment. Results: The study showed thatthere was a statistical significant difference in the median value of difference in visual analogue scale between groups A [7.0 (5.0-10.0)] and B [8.0 (6.0-10.0)] (which was in favor to group B, more decrease) with Z value = -2.672 and p value = 0.008,there was a statistical significant difference in the median value of difference in patient rated wrist evaluation questionnaire between group A [59.0 (44.0-71.0)] and B [69.0 (63.0-77.0)] (which was in favor to group B, more decrease] with Z value = -3.760 and p value = 0.001, Also there was a statistical significant decrease in the mean value of coritsol level in group B (17.07 ± 1.96) when compared with its corresponding level in group A (18.70 ± 2.27) with (F= 18.041 and p= 0.001). Conclusion:myofascial release could be used as a complementary treatment in reducing pain, soreness and adhesion and decreasing the need of analgesic drugs

Issued also as CD